Comparison of the Efficacy of Tolterodine and Oxybutynin in Different Urodynamic Severity Grades of Idiopathic Detrusor Overactivity

To compare the efficacy of tolterodine and oxybutynin in the treatment of specific, according to their urodynamic grade of severity, populations with overactive detrusor. In this open, randomized, two-way crossover study 128 women with urodynamically confirmed, idiopathic detrusor overactivity were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European urology 2004-12, Vol.46 (6), p.776-783
Hauptverfasser: Giannitsas, K., Perimenis, P., Athanasopoulos, A., Gyftopoulos, K., Nikiforidis, G., Barbalias, G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 783
container_issue 6
container_start_page 776
container_title European urology
container_volume 46
creator Giannitsas, K.
Perimenis, P.
Athanasopoulos, A.
Gyftopoulos, K.
Nikiforidis, G.
Barbalias, G.
description To compare the efficacy of tolterodine and oxybutynin in the treatment of specific, according to their urodynamic grade of severity, populations with overactive detrusor. In this open, randomized, two-way crossover study 128 women with urodynamically confirmed, idiopathic detrusor overactivity were recruited. Patients were categorized in 4 grades of severity groups, according to the characteristics of the first overactive detrusor contraction during filling cystometrogram: high volume–low pressure (grade-group I), high volume–high pressure (grade-group II), low volume–low pressure (grade-group III) and low volume–high pressure (grade-group IV). The primary outcome measure was average volume of voided urine per micturition. 107 patients successfully completed the study protocol and were included in the analyses: 40 in group IV, 36 in III, 25 in II and 6 in group I. In groups IV and III both oxybutynin and tolterodine significantly increased the average volume of voided urine per micturition but the differences between the drugs were not significant ( p > 0.05). In group II neither of the drugs achieved significant changes in the outcome measure ( p > 0.05). Tolterodine and oxybutynin are clinically equipotent in treating detrusor overactivity in specific severity groups of patients, although urodynamic effects are somewhat different.
doi_str_mv 10.1016/j.eururo.2004.07.021
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67088651</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0302283804003756</els_id><sourcerecordid>67088651</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-9b1fbe961e0270e49e1e62e6bd30e28da18a094178a215239d136cc1fc2431da3</originalsourceid><addsrcrecordid>eNp9kM1q3DAUhUVpaSY_b1CKVt3ZuZL8I28KZZImgcAsmqyFLF0TDWNrKslDve-DV8MMdBcQCKHvnMv9CPnCoGTAmtttiXOYgy85QFVCWwJnH8iKyVYUbd3AR7ICAbzgUsgLchnjFgBE3YnP5ILVdSWrql2Rv2s_7nVw0U_UDzS9Ib0fBme0WY7vF79LGLx1E1I9Wbr5s_RzWiY30Xzu3DBgwCnR18wskx6dob_wgMGlhT4EbTEeW56s83ud3vLvHaYwRx_oJlPaJHfI6DX5NOhdxJvzfUVef96_rB-L583D0_rHc2GEFKnoejb02DUMgbeAVYcMG45NbwUgl1YzqaGrWCs1ZzUXnWWiMYYNhleCWS2uyLdT7z743zPGpEYXDe52ekI_R9W0IGVTswxWJ9AEH2PAQe2DG3VYFAN1tK-26mRfHe0raFW2n2Nfz_1zP6L9HzrrzsD3E4B5y4PDoKJxOBm0LqBJynr3_oR_wDKawA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67088651</pqid></control><display><type>article</type><title>Comparison of the Efficacy of Tolterodine and Oxybutynin in Different Urodynamic Severity Grades of Idiopathic Detrusor Overactivity</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Giannitsas, K. ; Perimenis, P. ; Athanasopoulos, A. ; Gyftopoulos, K. ; Nikiforidis, G. ; Barbalias, G.</creator><creatorcontrib>Giannitsas, K. ; Perimenis, P. ; Athanasopoulos, A. ; Gyftopoulos, K. ; Nikiforidis, G. ; Barbalias, G.</creatorcontrib><description>To compare the efficacy of tolterodine and oxybutynin in the treatment of specific, according to their urodynamic grade of severity, populations with overactive detrusor. In this open, randomized, two-way crossover study 128 women with urodynamically confirmed, idiopathic detrusor overactivity were recruited. Patients were categorized in 4 grades of severity groups, according to the characteristics of the first overactive detrusor contraction during filling cystometrogram: high volume–low pressure (grade-group I), high volume–high pressure (grade-group II), low volume–low pressure (grade-group III) and low volume–high pressure (grade-group IV). The primary outcome measure was average volume of voided urine per micturition. 107 patients successfully completed the study protocol and were included in the analyses: 40 in group IV, 36 in III, 25 in II and 6 in group I. In groups IV and III both oxybutynin and tolterodine significantly increased the average volume of voided urine per micturition but the differences between the drugs were not significant ( p &gt; 0.05). In group II neither of the drugs achieved significant changes in the outcome measure ( p &gt; 0.05). Tolterodine and oxybutynin are clinically equipotent in treating detrusor overactivity in specific severity groups of patients, although urodynamic effects are somewhat different.</description><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>DOI: 10.1016/j.eururo.2004.07.021</identifier><identifier>PMID: 15548447</identifier><language>eng</language><publisher>Switzerland: Elsevier B.V</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Benzhydryl Compounds - therapeutic use ; Cresols - therapeutic use ; Cross-Over Studies ; Female ; Humans ; Mandelic Acids - therapeutic use ; Middle Aged ; Muscarinic Antagonists - therapeutic use ; Overactive bladder ; Oxybutynin ; Phenylpropanolamine - therapeutic use ; Severity ; Severity of Illness Index ; Tolterodine ; Tolterodine Tartrate ; Treatment ; Urinary Incontinence - drug therapy ; Urinary Incontinence - physiopathology ; Urodynamics</subject><ispartof>European urology, 2004-12, Vol.46 (6), p.776-783</ispartof><rights>2004 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-9b1fbe961e0270e49e1e62e6bd30e28da18a094178a215239d136cc1fc2431da3</citedby><cites>FETCH-LOGICAL-c383t-9b1fbe961e0270e49e1e62e6bd30e28da18a094178a215239d136cc1fc2431da3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.eururo.2004.07.021$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15548447$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Giannitsas, K.</creatorcontrib><creatorcontrib>Perimenis, P.</creatorcontrib><creatorcontrib>Athanasopoulos, A.</creatorcontrib><creatorcontrib>Gyftopoulos, K.</creatorcontrib><creatorcontrib>Nikiforidis, G.</creatorcontrib><creatorcontrib>Barbalias, G.</creatorcontrib><title>Comparison of the Efficacy of Tolterodine and Oxybutynin in Different Urodynamic Severity Grades of Idiopathic Detrusor Overactivity</title><title>European urology</title><addtitle>Eur Urol</addtitle><description>To compare the efficacy of tolterodine and oxybutynin in the treatment of specific, according to their urodynamic grade of severity, populations with overactive detrusor. In this open, randomized, two-way crossover study 128 women with urodynamically confirmed, idiopathic detrusor overactivity were recruited. Patients were categorized in 4 grades of severity groups, according to the characteristics of the first overactive detrusor contraction during filling cystometrogram: high volume–low pressure (grade-group I), high volume–high pressure (grade-group II), low volume–low pressure (grade-group III) and low volume–high pressure (grade-group IV). The primary outcome measure was average volume of voided urine per micturition. 107 patients successfully completed the study protocol and were included in the analyses: 40 in group IV, 36 in III, 25 in II and 6 in group I. In groups IV and III both oxybutynin and tolterodine significantly increased the average volume of voided urine per micturition but the differences between the drugs were not significant ( p &gt; 0.05). In group II neither of the drugs achieved significant changes in the outcome measure ( p &gt; 0.05). Tolterodine and oxybutynin are clinically equipotent in treating detrusor overactivity in specific severity groups of patients, although urodynamic effects are somewhat different.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Benzhydryl Compounds - therapeutic use</subject><subject>Cresols - therapeutic use</subject><subject>Cross-Over Studies</subject><subject>Female</subject><subject>Humans</subject><subject>Mandelic Acids - therapeutic use</subject><subject>Middle Aged</subject><subject>Muscarinic Antagonists - therapeutic use</subject><subject>Overactive bladder</subject><subject>Oxybutynin</subject><subject>Phenylpropanolamine - therapeutic use</subject><subject>Severity</subject><subject>Severity of Illness Index</subject><subject>Tolterodine</subject><subject>Tolterodine Tartrate</subject><subject>Treatment</subject><subject>Urinary Incontinence - drug therapy</subject><subject>Urinary Incontinence - physiopathology</subject><subject>Urodynamics</subject><issn>0302-2838</issn><issn>1873-7560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kM1q3DAUhUVpaSY_b1CKVt3ZuZL8I28KZZImgcAsmqyFLF0TDWNrKslDve-DV8MMdBcQCKHvnMv9CPnCoGTAmtttiXOYgy85QFVCWwJnH8iKyVYUbd3AR7ICAbzgUsgLchnjFgBE3YnP5ILVdSWrql2Rv2s_7nVw0U_UDzS9Ib0fBme0WY7vF79LGLx1E1I9Wbr5s_RzWiY30Xzu3DBgwCnR18wskx6dob_wgMGlhT4EbTEeW56s83ud3vLvHaYwRx_oJlPaJHfI6DX5NOhdxJvzfUVef96_rB-L583D0_rHc2GEFKnoejb02DUMgbeAVYcMG45NbwUgl1YzqaGrWCs1ZzUXnWWiMYYNhleCWS2uyLdT7z743zPGpEYXDe52ekI_R9W0IGVTswxWJ9AEH2PAQe2DG3VYFAN1tK-26mRfHe0raFW2n2Nfz_1zP6L9HzrrzsD3E4B5y4PDoKJxOBm0LqBJynr3_oR_wDKawA</recordid><startdate>20041201</startdate><enddate>20041201</enddate><creator>Giannitsas, K.</creator><creator>Perimenis, P.</creator><creator>Athanasopoulos, A.</creator><creator>Gyftopoulos, K.</creator><creator>Nikiforidis, G.</creator><creator>Barbalias, G.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041201</creationdate><title>Comparison of the Efficacy of Tolterodine and Oxybutynin in Different Urodynamic Severity Grades of Idiopathic Detrusor Overactivity</title><author>Giannitsas, K. ; Perimenis, P. ; Athanasopoulos, A. ; Gyftopoulos, K. ; Nikiforidis, G. ; Barbalias, G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-9b1fbe961e0270e49e1e62e6bd30e28da18a094178a215239d136cc1fc2431da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Benzhydryl Compounds - therapeutic use</topic><topic>Cresols - therapeutic use</topic><topic>Cross-Over Studies</topic><topic>Female</topic><topic>Humans</topic><topic>Mandelic Acids - therapeutic use</topic><topic>Middle Aged</topic><topic>Muscarinic Antagonists - therapeutic use</topic><topic>Overactive bladder</topic><topic>Oxybutynin</topic><topic>Phenylpropanolamine - therapeutic use</topic><topic>Severity</topic><topic>Severity of Illness Index</topic><topic>Tolterodine</topic><topic>Tolterodine Tartrate</topic><topic>Treatment</topic><topic>Urinary Incontinence - drug therapy</topic><topic>Urinary Incontinence - physiopathology</topic><topic>Urodynamics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Giannitsas, K.</creatorcontrib><creatorcontrib>Perimenis, P.</creatorcontrib><creatorcontrib>Athanasopoulos, A.</creatorcontrib><creatorcontrib>Gyftopoulos, K.</creatorcontrib><creatorcontrib>Nikiforidis, G.</creatorcontrib><creatorcontrib>Barbalias, G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Giannitsas, K.</au><au>Perimenis, P.</au><au>Athanasopoulos, A.</au><au>Gyftopoulos, K.</au><au>Nikiforidis, G.</au><au>Barbalias, G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of the Efficacy of Tolterodine and Oxybutynin in Different Urodynamic Severity Grades of Idiopathic Detrusor Overactivity</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2004-12-01</date><risdate>2004</risdate><volume>46</volume><issue>6</issue><spage>776</spage><epage>783</epage><pages>776-783</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><abstract>To compare the efficacy of tolterodine and oxybutynin in the treatment of specific, according to their urodynamic grade of severity, populations with overactive detrusor. In this open, randomized, two-way crossover study 128 women with urodynamically confirmed, idiopathic detrusor overactivity were recruited. Patients were categorized in 4 grades of severity groups, according to the characteristics of the first overactive detrusor contraction during filling cystometrogram: high volume–low pressure (grade-group I), high volume–high pressure (grade-group II), low volume–low pressure (grade-group III) and low volume–high pressure (grade-group IV). The primary outcome measure was average volume of voided urine per micturition. 107 patients successfully completed the study protocol and were included in the analyses: 40 in group IV, 36 in III, 25 in II and 6 in group I. In groups IV and III both oxybutynin and tolterodine significantly increased the average volume of voided urine per micturition but the differences between the drugs were not significant ( p &gt; 0.05). In group II neither of the drugs achieved significant changes in the outcome measure ( p &gt; 0.05). Tolterodine and oxybutynin are clinically equipotent in treating detrusor overactivity in specific severity groups of patients, although urodynamic effects are somewhat different.</abstract><cop>Switzerland</cop><pub>Elsevier B.V</pub><pmid>15548447</pmid><doi>10.1016/j.eururo.2004.07.021</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0302-2838
ispartof European urology, 2004-12, Vol.46 (6), p.776-783
issn 0302-2838
1873-7560
language eng
recordid cdi_proquest_miscellaneous_67088651
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adult
Aged
Aged, 80 and over
Benzhydryl Compounds - therapeutic use
Cresols - therapeutic use
Cross-Over Studies
Female
Humans
Mandelic Acids - therapeutic use
Middle Aged
Muscarinic Antagonists - therapeutic use
Overactive bladder
Oxybutynin
Phenylpropanolamine - therapeutic use
Severity
Severity of Illness Index
Tolterodine
Tolterodine Tartrate
Treatment
Urinary Incontinence - drug therapy
Urinary Incontinence - physiopathology
Urodynamics
title Comparison of the Efficacy of Tolterodine and Oxybutynin in Different Urodynamic Severity Grades of Idiopathic Detrusor Overactivity
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T14%3A00%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20the%20Efficacy%20of%20Tolterodine%20and%20Oxybutynin%20in%20Different%20Urodynamic%20Severity%20Grades%20of%20Idiopathic%20Detrusor%20Overactivity&rft.jtitle=European%20urology&rft.au=Giannitsas,%20K.&rft.date=2004-12-01&rft.volume=46&rft.issue=6&rft.spage=776&rft.epage=783&rft.pages=776-783&rft.issn=0302-2838&rft.eissn=1873-7560&rft_id=info:doi/10.1016/j.eururo.2004.07.021&rft_dat=%3Cproquest_cross%3E67088651%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67088651&rft_id=info:pmid/15548447&rft_els_id=S0302283804003756&rfr_iscdi=true